Luminar Technologies, Inc. short interest in 2025
In 2025, Luminar Technologies, Inc.'s disclosed short interest ran from 16.71% of shares outstanding on 14 Mar 2025 to 24.58% on 15 Dec 2025, a change of +7.87 percentage points. The year's high was 27.28% on 28 Nov 2025 and its low 15.26% on 15 Jul 2025, averaging 19.89% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.09 days on 14 Mar 2025. Full history: Luminar Technologies, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025
2025 in figures
- Start of year
- 16.71% (14 Mar 2025)
- End of year
- 24.58% (15 Dec 2025)
- Change
- +7.87 pp
- High
- 27.28% (28 Nov 2025)
- Low
- 15.26% (15 Jul 2025)
- Average
- 19.89%
- Highest days to cover
- 6.09 (14 Mar 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Mar 2025 | 16.71% | 6.09 | |
| 31 Mar 2025 | 18.49% | 1.35 | results (8-K), 10-K filed |
| 15 Apr 2025 | 21.55% | 4.12 | |
| 30 Apr 2025 | 18.92% | 4.47 | |
| 15 May 2025 | 18.37% | 4.30 | results (8-K) |
| 30 May 2025 | 18.99% | 4.09 | 10-Q filed |
| 13 Jun 2025 | 21.32% | 3.48 | |
| 30 Jun 2025 | 20.55% | 3.19 | |
| 15 Jul 2025 | 15.26% | 2.91 | |
| 31 Jul 2025 | 17.72% | 1.60 | |
| 15 Aug 2025 | 16.17% | 2.64 | results (8-K), 10-Q filed |
| 29 Aug 2025 | 17.37% | 2.98 | |
| 15 Sep 2025 | 19.29% | 3.68 | |
| 30 Sep 2025 | 18.80% | 2.36 | |
| 15 Oct 2025 | 18.62% | 1.69 | |
| 31 Oct 2025 | 21.12% | 1.08 | results (8-K) |
| 14 Nov 2025 | 26.71% | 2.26 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 27.28% | 4.02 | |
| 15 Dec 2025 | 24.58% | 1.85 |
See also: Luminar Technologies, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.